Flecainide effectively treated ventricular arrhythmias in 81% of patients, significantly reducing premature ventricular contractions and ventricular tachycardia. This antiarrhythmic drug demonstrated a high success rate with no severe side effects reported.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: